Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

Simon Körver; Ulla Feldt-Rasmussen; Einar Svarstad; Ilkka Kantola; Mirjam Langeveld

doi:https://doi.org/10.1002/cpt.1536

Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

Simon Körver, Ulla Feldt-Rasmussen, Einar Svarstad, Ilkka Kantola, Mirjam Langeveld

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Original language	English
Pages (from-to)	925-926
Journal	Clinical Pharmacology and Therapeutics
Volume	106
Issue number	5
DOIs	https://doi.org/10.1002/cpt.1536
Publication status	Published - Nov 2019

Access to Document

https://doi.org/10.1002/cpt.1536

Cite this

@article{1a2be5f2430c4729b5f05efdfbd588db,

title = "Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data",

author = "Simon K{\"o}rver and Ulla Feldt-Rasmussen and Einar Svarstad and Ilkka Kantola and Mirjam Langeveld",

year = "2019",

month = nov,

doi = "https://doi.org/10.1002/cpt.1536",

language = "English",

volume = "106",

pages = "925--926",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

AU - Körver, Simon

AU - Feldt-Rasmussen, Ulla

AU - Svarstad, Einar

AU - Kantola, Ilkka

AU - Langeveld, Mirjam

PY - 2019/11

Y1 - 2019/11

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068888303&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31298736

U2 - https://doi.org/10.1002/cpt.1536

DO - https://doi.org/10.1002/cpt.1536

M3 - Comment/Letter to the editor

C2 - 31298736

SN - 0009-9236

VL - 106

SP - 925

EP - 926

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 5

ER -

Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

Access to Document

Other files and links

Cite this